About FDA
Number of presentations/participation at U.S. conferences, stakeholder meetings, and trainings during the month
Dictionary: One of OSMP’s primary functions is to train and communicate OSMP issues both internally with FDA staff, and externally with the regulated industry. OSMP staff is frequently invited to participate at universities, conferences, workshops, and training sessions. These activities are intended to foster efficiency and innovative product development, expedite the premarket review process, and enhance the safe and ethical development of therapies by increasing understanding and transparency of the complex regulatory issues raised by medical products.
Information is current as of December 31, 2012.
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 50 |
| Nov 2011 | N/A | 23 |
| Dec 2011 | N/A | 28 |
| Jan 2012 | N/A | 24 |
| Feb 2012 | N/A | 26 |
| Mar 2012 | N/A | 39 |
| Apr 2012 | N/A | 30 |
| May 2012 | N/A | 45 |
| Jun 2012 | N/A | 30 |
| Jul 2012 | N/A | 15 |
| Aug 2012 | N/A | 27 |
| Sep 2012 | N/A | 69 |
FY 2012 Total: 406
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
